Xingzhe Ma

3.5k total citations · 3 hit papers
25 papers, 2.6k citations indexed

About

Xingzhe Ma is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Xingzhe Ma has authored 25 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Xingzhe Ma's work include Cholesterol and Lipid Metabolism (10 papers), Cancer, Lipids, and Metabolism (7 papers) and interferon and immune responses (5 papers). Xingzhe Ma is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Cancer, Lipids, and Metabolism (7 papers) and interferon and immune responses (5 papers). Xingzhe Ma collaborates with scholars based in China, United States and France. Xingzhe Ma's co-authors include Qing Yi, Jianfei Qian, Enguang Bi, Maojie Yang, Lintao Liu, Qiang Wang, Liuling Xiao, Su Pan, Lingqun Ye and Yong Lu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xingzhe Ma

25 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

2019 697 citations Xingzhe Ma, Enguang Bi et al. Cell Metabolism profile →
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability

2021 664 citations Xingzhe Ma, Liuling Xiao et al. Cell Metabolism profile →
Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages

2020 360 citations Pan Su, Qiang Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingzhe Ma China	19	1.2k	1.1k	1.1k	770	556	25	2.6k
Enguang Bi China	20	1.6k 1.3×	1.1k 1.0×	1.2k 1.1×	919 1.2×	570 1.0×	42	3.1k
Maojie Yang United States	14	957 0.8×	1.0k 0.9×	962 0.9×	671 0.9×	546 1.0×	20	2.3k
Lintao Liu China	14	809 0.7×	925 0.9×	879 0.8×	584 0.8×	534 1.0×	29	2.1k
Seung-Oe Lim United States	15	843 0.7×	969 0.9×	1.8k 1.7×	1.6k 2.1×	546 1.0×	17	3.4k
Dominique C. Hinshaw United States	8	887 0.8×	708 0.7×	1.2k 1.1×	989 1.3×	669 1.2×	23	2.4k
David Kung‐Chun Chiu Hong Kong	21	655 0.6×	1.4k 1.3×	2.2k 2.1×	743 1.0×	367 0.7×	36	3.3k
Jiang Liu China	17	901 0.8×	1.1k 1.1×	1.9k 1.8×	1.4k 1.8×	950 1.7×	33	3.4k
Yuping Sun China	27	831 0.7×	413 0.4×	818 0.8×	1.3k 1.7×	502 0.9×	87	2.4k
Hirokazu Okayama Japan	30	604 0.5×	721 0.7×	1.3k 1.2×	962 1.2×	392 0.7×	92	2.4k
Yoshihisa Tokumaru Japan	28	507 0.4×	859 0.8×	1.1k 1.0×	1.1k 1.4×	714 1.3×	91	2.2k

Countries citing papers authored by Xingzhe Ma

Since Specialization

Citations

This map shows the geographic impact of Xingzhe Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingzhe Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingzhe Ma more than expected).

Fields of papers citing papers by Xingzhe Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingzhe Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingzhe Ma. The network helps show where Xingzhe Ma may publish in the future.

Co-authorship network of co-authors of Xingzhe Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xingzhe Ma. A scholar is included among the top collaborators of Xingzhe Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingzhe Ma. Xingzhe Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Liuling, Rui Duan, Chuanchao Zhang, et al.. (2025). Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss. Nature Cancer. 6(4). 718–735. 2 indexed citations

Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations

Ma, Xingzhe, Liuling Xiao, Lintao Liu, et al.. (2021). CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metabolism. 33(5). 1001–1012.e5. 664 indexed citations breakdown →

Su, Pan, Qiang Wang, Enguang Bi, et al.. (2020). Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages. Cancer Research. 80(7). 1438–1450. 360 indexed citations breakdown →

Wang, Qiang, Dongyu Zhao, Miao Xian, et al.. (2020). MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma. Blood. 136(22). 2557–2573. 38 indexed citations

Liu, Lintao, Enguang Bi, Xingzhe Ma, et al.. (2020). Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9. Nature Communications. 11(1). 5902–5902. 72 indexed citations

Ma, Xingzhe, Enguang Bi, Yong Lu, et al.. (2019). Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. Cell Metabolism. 30(1). 143–156.e5. 697 indexed citations breakdown →

Qian, Jianfei, Qiang Wang, Lintao Liu, et al.. (2019). Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies. Blood. 134(Supplement_1). 5551–5551. 1 indexed citations

Ma, Xingzhe, Enguang Bi, Chunjian Huang, et al.. (2018). Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity. The Journal of Experimental Medicine. 215(6). 1555–1569. 118 indexed citations

10.

Liu, Ying, Wei Zhuo, Xingzhe Ma, et al.. (2018). 25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism. Journal of Lipid Research. 59(3). 439–451. 61 indexed citations

11.

Liu, Ying, Wei Zhuo, Ye Zhang, et al.. (2018). Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol. Journal of Lipid Research. 59(12). 2287–2296. 23 indexed citations

12.

Lu, Yong, Qiang Wang, Gang Xue, et al.. (2018). Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell. 33(6). 1048–1060.e7. 121 indexed citations

13.

Bi, Enguang, Rong Li, Laura Bover, et al.. (2018). E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. Journal of Clinical Investigation. 128(11). 4821–4831. 31 indexed citations

14.

Wang, Qixue, Lei Sun, Xiaoxiao Yang, et al.. (2016). Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice. Scientific Reports. 6(1). 27295–27295. 20 indexed citations

15.

Zhao, Yinghua, Xiao Chu, Jintong Chen, et al.. (2016). Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nature Communications. 7(1). 12368–12368. 107 indexed citations

16.

Liu, Ying, Qixue Wang, Xingzhe Ma, et al.. (2016). Activation of LXR inhibits the Development of Pulmonary Carcinomas Induced by 3‐Methylcholanthrene and Butylated Hydroxytoluene. The FASEB Journal. 30(S1). 1 indexed citations

17.

Ma, Xingzhe, Ying Liu, Qixue Wang, et al.. (2015). Tamoxifen induces the development of hernia in mice by activating MMP-2 and MMP-13 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 1038–1048. 22 indexed citations

18.

Yang, Xiaoxiao, Hui Yao, Yuanli Chen, et al.. (2015). Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake. Journal of Biological Chemistry. 290(36). 21788–21799. 48 indexed citations

19.

Liu, Mengyang, Yuanli Chen, Ling Zhang, et al.. (2015). Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase II. Journal of Biological Chemistry. 290(23). 14418–14429. 7 indexed citations

20.

Zhang, Ling, Meixiu Jiang, Yuanli Chen, et al.. (2013). DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux—An LXR-dependent mechanism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(6). 1134–1145. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact